|| powered by |
Daniel Anderson from the Massachusetts Institute of Technology (MIT) at the 3rd World Congress on Regenerative Medicine11.10.2007 - (idw) Fraunhofer-Gesellschaft
With only few days left until the 3rd World Congress on Regenerative Medicine (WCRM) in the Congress Centre in the city of Leipzig, public interest turns towards the various themes surrounding regenerative medicine. These topics include stem cell therapies for diverse diseases, new biomaterials, tissue engineering as well as regenerative medicine in veterinary medicine represented within the satellite event of the WCRM: the Fraunhofer Symposium. The main program is immediately available on the homepage http://www.regmed.org. Approximately 700 participants from 33 countries from every continent have already registered. The online registration for this important event from October, 17 to 20, 2007 is still possible. Students obtain a special offer: For only 150 euros they can experience the scientific program for the entire three days. Day tickets are available from 80 euros.
On Saturday, October, 20, 2007 Daniel Anderson from the Massachusetts Institute of Technology (MIT), Cambridge, (USA) will give an oral presentation. Anderson works as research associate at the Center for Cancer Research of MIT and is active in the well known biomedical engineering laboratory at MIT. The director of this lab is Prof. Robert Langer. He became famous through his revolutionary work in the field of cancer research and the new developed methods of drug administration to cancer patients. In 1999 Forbes Magazine named him one of the 25 worldwide most important persons in the field of biotechnology. The laboratory works at the interface of biotechnology and material science. At the 3rd WCRM Anderson will, as representative of the Langer-Lab, speak about "Combinatorial development of biomaterials for tissue engineering and drug delivery".
Further information about the world congress under http://www.regmed.org.
HTML-Code zum Verweis auf diese Seite:
<a href="http://www.uni-protokolle.de/nachrichten/id/144842/">Daniel Anderson from the Massachusetts Institute of Technology (MIT) at the 3rd World Congress on Regenerative Medicine </a>